Activation of the Wnt and β‐catenin pathway has been demonstrated in liver, pancreatic, ovarian, and colorectal and other cancers.39 Here, we observed that C3a treatment augmented β‐catenin expression, whereas it repressed GSK‐3β expression. The gene discussed is GSK3B; the disease is cancer.